Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Northwestern University
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
University of Washington
National Cancer Institute (NCI)
Samsung Medical Center
M.D. Anderson Cancer Center
Asan Medical Center
M.D. Anderson Cancer Center
Northwestern University
UNC Lineberger Comprehensive Cancer Center